La Jolla Pharmaceutical Company
www.lajollapharmaceutical.comLa Jolla Pharmaceutical Company is dedicated to the commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases. La Jolla markets GIAPREZA® (angiotensin II) injection and XERAVA® (eravacycline) for injection. For more information, please visit www.ljpc.com.
Read more
La Jolla Pharmaceutical Company is dedicated to the commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases. La Jolla markets GIAPREZA® (angiotensin II) injection and XERAVA® (eravacycline) for injection. For more information, please visit www.ljpc.com.
Read more
Country
State
Massachusetts
City (Headquarters)
Waltham
Industry
Founded
1989
Estimated Revenue
$10,000,000 to $50,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Director Medical Affairs
Email ****** @****.comPhone (***) ****-****Senior Director , Pharmaceutical Operations
Email ****** @****.comPhone (***) ****-****Director , Pharmaceutical Operations
Email ****** @****.comPhone (***) ****-****Senior Sap Fico and C.O.E Manager
Email ****** @****.comPhone (***) ****-****
Technologies
(3)
Reach decision makers at La Jolla Pharmaceutical Company
Free credits every month!
La Jolla Pharmaceutical Company FAQ
Waltham, United States
Pharmaceutical Manufacturing
